COA/KL-2026-009Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
KLOW 80 mg
KL-2026-009Lot BBL-KL80-1126Analyzed November 7, 2026
Timeline
Ordered
November 4, 2026
Received
November 5, 2026
Analyzed
November 7, 2026
Sample
Name
KLOW 80 mg
Expected
KLOW blend (GHK-Cu, BPC-157, TB-500, KPV)
Amount
1 vial, lyophilized powder
Testing
Client
Bella BioLabs
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
GHK-Cu69.3mg
Label claim: 50 mg
BPC-15712.00mg
Label claim: 10 mg
TB-5009.88mg
Label claim: 10 mg
KPV10.09mg
Label claim: 10 mg
Purity, how clean it is
>99.9%
Measured, not estimated. Purity is calculated from the full chromatogram shown above, and no impurity peaks were detected above the reporting threshold. Results of 99.95% or higher are reported as >99.9%, as 100% purity cannot be demonstrated analytically.
Chromatograms
BPC-157 / TB-500
HPLC-UV
11.45 min, BPC-157, 60.7%
12.40 min, TB-500, 39.2%
GHK-Cu / KPV
HPLC-UV
2.58 min, GHK-Cu
3.65 min, KPV
Analyst Comments
Blue lyophilized powder, orange-cap vial, received sealed. GHK-Cu and KPV were measured on a second HPLC-UV method; both chromatograms are shown.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 7, 2026
Verification Code
KL-2GJR-QST0
Verify at purilab.org/verify/KL-2GJR-QST0
Scan to Verify
KL-2GJR-QST0
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1